Dr. Aurelie Minne

Active

Private limited companyfounded 2018active for 7 yearsRoeselaarsestraat 590, 8870 Izegem, BelgiumKBO/BCE: BE 0712.844.189

From the official registers: KBO 7 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Aurelie Minne has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €129,086 and a net result of €110,486. Equity remains stable across the filed financial years (±0.2% per year). Its solvency ranks better than 48% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

Dr. Aurelie MinneActiveChecked score 94/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 05-11-2018 Normal situation
Legal form: Private limited company
Registered office: Roeselaarsestraat 590, 8870 Izegem
Activity: Specialist medical practice NACE 86220and 1 other
Establishment unit: 2.282.321.908 8800 Roeselare, since 05-11-2018
Financial year end: 31 December
Peppol: Reachable since 02-10-2024

Company details

Who decides

Board

Minne AurelieDirector

Board & ownership

How it is doing

94 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Annual accounts 2025

Gross margin: €151,217; ▼ 12.8%
Turnover: ≈ €280,000; estimated
Profit: €110,486; ▼ 14.2%
Equity: €129,086; ▼ 12.4%
Total assets: €212,079; ▲ 37.5%

2025 accounts 31 days early

Filed on 30-06-2026at the National Bank

Financials

Why 94lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 30.98, cash €41,834Figures for financial year 2025 (filed 30-06-2026)Equity €129,086 (60.9% of total assets)Show the evidence

Checked score

Score 2025

94 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 53% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 86-14

equity 60.9% of total assets

Liquidity 75-25

short-term debt 3.1% · cash 19.7%

Profitability 100=

return on assets 52.1%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: 0.1%▲ +0.1 percentage points vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%▼ -0.1 percentage points vs 06-2025lowest value 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €12,000 on 30-day terms is acceptable

Liquidity ample (current ratio 30.98, compared with 20.15 in 2024, above the usual 1.5; short-term debt: 3.1% and cash: 19.7% of total assets), and 39.1% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 49% on solvency, 56% on liquidity, 80% on profitability and 25% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskneutral

Sector: Human health activities (NACE 86)

KBO

Liquidity: current ratio 30.98, cash €41,834

NBB · annual accounts

Figures for financial year 2025 (filed 30-06-2026)

NBB · annual accounts

Equity €129,086 (60.9% of total assets)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.

NBB · 7 filings

Deviation from the deadline

2025

31 days early

2024

36 days early

2023

15 days early

2022

15 days early

2021

33 days early

2020

11 days late

2019

34 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 12 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 June (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: 7 profitable years in a rowprofit 2025: €110,486 7 years View
Positive: Filed on time since financial year 2021accounts within the deadline every year 5 years View

Documents

Key facts about Dr. Aurelie Minne

What is the company number of Dr. Aurelie Minne?: 0712.844.189. In Belgium the VAT number is the company number with BE in front: BE 0712.844.189.
Where is Dr. Aurelie Minne based?: The registered office is at Roeselaarsestraat 590, 8870 Izegem.Company details
What does Dr. Aurelie Minne do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Aurelie Minne?: Private limited company (BV).
When was Dr. Aurelie Minne founded?: On 05-11-2018.
Is Dr. Aurelie Minne still active?: Yes, Dr. Aurelie Minne is an active enterprise in the KBO register.
What is the turnover of Dr. Aurelie Minne?: ≈ €280,000 in financial year 2025. Estimated from the gross margin of €151,217: probably between €240,000 and €370,000, based on 43 comparable companies, NACE 86220.Financials
Is Dr. Aurelie Minne profitable?: In financial year 2025, Dr. Aurelie Minne made a profit of €110,486.
Where can I find the annual accounts of Dr. Aurelie Minne?: Dr. Aurelie Minne filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. Aurelie Minne due?: By 31-07-2027, for financial year 2026.Timeline